<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35951045</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1084</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>European radiology</Title><ISOAbbreviation>Eur Radiol</ISOAbbreviation></Journal><ArticleTitle>Iron quantitative analysis of motor combined with bulbar region in M1 cortex may improve diagnosis performance in ALS.</ArticleTitle><Pagination><StartPage>1132</StartPage><EndPage>1142</EndPage><MedlinePgn>1132-1142</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00330-022-09045-2</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To explore whether the combined analysis of motor and bulbar region of M1 on susceptibility-weighted imaging (SWI) can be a valid biomarker for amyotrophic lateral sclerosis (ALS).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Thirty-two non-demented ALS patients and 35 age- and gender-matched healthy controls (HC) were retrospectively recruited. SWI and 3D-T1-MPRAGE images were obtained from all individuals using a 3.0-T MRI scan. The bilateral posterior band of M1 was manually delineated by three neuroradiologists on phase images and subdivided into the motor and bulbar regions. We compared the phase values in two groups and performed a stratification analysis (ALSFRS-R score, duration, disease progression rate, and onset). Receiver operating characteristic (ROC) curves were also constructed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">ALS group showed significantly increased phase values in M1 and the two subregions than the HC group, on the all and elderly level (p &lt; 0.001, respectively). On all-age level comparison, negative correlations were found between phase values of M1 and clinical score and duration (p &lt; 0.05, respectively). Similar associations were found in the motor region (p &lt; 0.05, respectively). On both the total (p &lt; 0.01) and elderly (p &lt; 0.05) levels, there were positive relationships between disease progression rate and M1 phase values. In comparing ROC curves, the entire M1 showed the best diagnostic performance.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Combining motor and bulbar analyses as an integral M1 region on SWI can improve ALS diagnosis performance, especially in the elderly. The phase value could be a valuable biomarker for ALS evaluation.</AbstractText><AbstractText Label="KEY POINTS" NlmCategory="CONCLUSIONS">&#x2022; Integrated analysis of the motor and bulbar as an entire M1 region on SWI can improve the diagnosis performance in ALS. &#x2022; Quantitative analysis of iron deposition by SWI measurement helps the clinical evaluation, especially for the elderly patients. &#x2022; Phase value, when combined with the disease progression rate, could be a valuable biomarker for ALS.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to European Society of Radiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bao</LastName><ForeName>Yifang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Radiology, Huashan Hospital, Fudan University, No. 12 Middle Wulumuqi Road, Jingan District, Shanghai, 200040, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Functional and Molecular Medical Imaging, Fudan University, Shanghai, 200040, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Huashan Hospital, Fudan University, Shanghai, 200040, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piao</LastName><ForeName>Sirong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Radiology, Huashan Hospital, Fudan University, No. 12 Middle Wulumuqi Road, Jingan District, Shanghai, 200040, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Functional and Molecular Medical Imaging, Fudan University, Shanghai, 200040, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Radiology, Huashan Hospital, Fudan University, No. 12 Middle Wulumuqi Road, Jingan District, Shanghai, 200040, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Functional and Molecular Medical Imaging, Fudan University, Shanghai, 200040, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Liqin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Radiology, Huashan Hospital, Fudan University, No. 12 Middle Wulumuqi Road, Jingan District, Shanghai, 200040, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Functional and Molecular Medical Imaging, Fudan University, Shanghai, 200040, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Haiqing</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Radiology, Huashan Hospital, Fudan University, No. 12 Middle Wulumuqi Road, Jingan District, Shanghai, 200040, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Functional and Molecular Medical Imaging, Fudan University, Shanghai, 200040, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geng</LastName><ForeName>Daoying</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Radiology, Huashan Hospital, Fudan University, No. 12 Middle Wulumuqi Road, Jingan District, Shanghai, 200040, China. gengdy@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Functional and Molecular Medical Imaging, Fudan University, Shanghai, 200040, China. gengdy@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yuxin</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-2107-6744</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Huashan Hospital, Fudan University, No. 12 Middle Wulumuqi Road, Jingan District, Shanghai, 200040, China. liyuxin@fudan.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Functional and Molecular Medical Imaging, Fudan University, Shanghai, 200040, China. liyuxin@fudan.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2019YFC0120602</GrantID><Agency>National Key R&amp;D Program of China</Agency><Country/></Grant><Grant><GrantID>61672236</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>19ZR1407900</GrantID><Agency>Science and Technology Commission of Shanghai Municipality</Agency><Country/></Grant><Grant><GrantID>2016QD15</GrantID><Agency>Scientific Research project of Huashan Hospital, Fudan University</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur Radiol</MedlineTA><NlmUniqueID>9114774</NlmUniqueID><ISSNLinking>0938-7994</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>E1UOL152H7</RegistryNumber><NameOfSubstance UI="D007501">Iron</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007501" MajorTopicYN="N">Iron</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009044" MajorTopicYN="Y">Motor Cortex</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Disease progression</Keyword><Keyword MajorTopicYN="N">Motor cortex</Keyword><Keyword MajorTopicYN="N">ROC curve</Keyword><Keyword MajorTopicYN="N">Susceptibility-weighted imaging</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>11</Day><Hour>11</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35951045</ArticleId><ArticleId IdType="doi">10.1007/s00330-022-09045-2</ArticleId><ArticleId IdType="pii">10.1007/s00330-022-09045-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brunet A, Stuart-Lopez G, Burg T et al (2020) Cortical circuit dysfunction as a potential driver of amyotrophic lateral sclerosis. Front Neurosci 14:363. https://doi.org/10.3389/fnins.2020.00363</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00363</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, Vucic S, Talbot K et al (2021) Improving clinical trial outcomes in amyotrophic lateral sclerosis. Nat Rev Neurol 17:104&#x2013;118. https://doi.org/10.1038/s41582-020-00434-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-00434-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Longinetti E, Fang F (2019) Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol 32:771&#x2013;776. https://doi.org/10.1097/WCO.0000000000000730</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000730</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, Vucic S, Cheah BC et al (2011) Amyotrophic lateral sclerosis. Lancet 377:942&#x2013;955. https://doi.org/10.1016/s0140-6736(10)61156-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(10)61156-7</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA, Hardiman O, Chio A et al (2017) Amyotrophic lateral sclerosis. Lancet 390:2084&#x2013;2098. https://doi.org/10.1016/S0140-6736(17)31287-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadzhieva M, Kirches E, Wilisch-Neumann A et al (2013) Dysregulation of iron protein expression in the G93A model of amyotrophic lateral sclerosis. Neuroscience 230:94&#x2013;101. https://doi.org/10.1016/j.neuroscience.2012.11.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2012.11.021</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan JY, Jeong SY, Van Gelderen P et al (2012) Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology. PLoS One 7:e35241. https://doi.org/10.1371/journal.pone.0035241</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0035241</ArticleId></ArticleIdList></Reference><Reference><Citation>Petillon C, Hergesheimer R, Puy H et al (2019) The relevancy of data regarding the metabolism of iron to our understanding of deregulated mechanisms in ALS; hypotheses and pitfalls. Front Neurosci 12:1031. https://doi.org/10.3389/fnins.2018.01031</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.01031</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreau C, Danel V, Devedjian JC et al (2018) Could conservative iron chelation lead to neuroprotection in amyotrophic lateral sclerosis? Antioxid Redox Signal 29:742&#x2013;748. https://doi.org/10.1089/ars.2017.7493</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2017.7493</ArticleId></ArticleIdList></Reference><Reference><Citation>Oba H, Araki T, Ohtomo K et al (1993) Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging. Radiology 189:843&#x2013;846. https://doi.org/10.1148/radiology.189.3.8234713</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiology.189.3.8234713</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta-Cabronero J, Betts MJ, Cardenas-Blanco A et al (2016) In vivo MRI mapping of brain iron deposition across the adult lifespan. J Neurosci 36:364&#x2013;374. https://doi.org/10.1523/JNEUROSCI.1907-15.2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1907-15.2016</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattarai A, Chen Z, Ward PGD et al (2020) Serial assessment of iron in the motor cortex in limb-onset amyotrophic lateral sclerosis using quantitative susceptibility mapping. Quant Imaging Med Surg 10:1465&#x2013;1476. https://doi.org/10.21037/qims-20-187</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/qims-20-187</ArticleId></ArticleIdList></Reference><Reference><Citation>Haacke EM, Xu Y, Cheng YC, Reichenbach JR (2004) Susceptibility weighted imaging (SWI). Magn Reson Med 52:612&#x2013;618. https://doi.org/10.1002/mrm.20198</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.20198</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattarai A, Egan GF, Talman P et al (2021) Magnetic resonance iron imaging in amyotrophic lateral sclerosis. J Magn Reson Imaging 55:1283&#x2013;1300. https://doi.org/10.1002/jmri.27530</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.27530</ArticleId></ArticleIdList></Reference><Reference><Citation>Kee Y, Liu Z, Zhou L et al (2017) Quantitative susceptibility mapping (QSM) algorithms: mathematical rationale and computational implementations. IEEE Trans Biomed Eng 64:2531&#x2013;2545. https://doi.org/10.1109/TBME.2017.2749298</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/TBME.2017.2749298</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheelakumari R, Madhusoodanan M, Radhakrishnan A et al (2015) A potential biomarker in amyotrophic lateral sclerosis: can assessment of brain iron deposition with SWI and corticospinal tract degeneration with DTI help? AJNR Am J Neuroradiol 37:252&#x2013;258. https://doi.org/10.3174/ajnr.A4524</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A4524</ArticleId></ArticleIdList></Reference><Reference><Citation>Haacke EM, Ayaz M, Khan A et al (2007) Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. J Magn Reson Imaging 26:256&#x2013;264. https://doi.org/10.1002/jmri.22987</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.22987</ArticleId></ArticleIdList></Reference><Reference><Citation>Roeben B, Wilke C, Bender B et al (2019) The motor band sign in ALS: presentations and frequencies in a consecutive series of ALS patients. J Neurol Sci 406:116440. https://doi.org/10.1016/j.jns.2019.116440</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2019.116440</ArticleId></ArticleIdList></Reference><Reference><Citation>Nnah I, Wessling-Resnick M (2018) Brain iron homeostasis: a focus on microglial iron. Pharmaceuticals 11:129. https://doi.org/10.3390/ph11040129</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph11040129</ArticleId></ArticleIdList></Reference><Reference><Citation>Adachi Y, Sato N, Saito Y et al (2015) Usefulness of SWI for the detection of iron in the motor cortex in amyotrophic lateral sclerosis. J Neuroimaging 25:443&#x2013;451. https://doi.org/10.1111/jon.12127</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jon.12127</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta-Cabronero J, Machts J, Schreiber S et al (2018) Quantitative susceptibility MRI to detect brain iron in amyotrophic lateral sclerosis. Radiology 289:195&#x2013;203. https://doi.org/10.1148/radiol.2018180112</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2018180112</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Foxley S, Ansorge O et al (2020) Methods for quantitative susceptibility and R2* mapping in whole post-mortem brains at 7T applied to amyotrophic lateral sclerosis. Neuroimage 222:117216. https://doi.org/10.1016/j.neuroimage.2020.117216</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2020.117216</ArticleId></ArticleIdList></Reference><Reference><Citation>Conte G, Sbaraini S, Morelli C et al (2021) A susceptibility-weighted imaging qualitative score of the motor cortex may be a useful tool for distinguishing clinical phenotypes in amyotrophic lateral sclerosis. Eur Radiol 31:1281&#x2013;1289. https://doi.org/10.1007/s00330-020-07239-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-020-07239-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293&#x2013;299. https://doi.org/10.1080/146608200300079536</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobel U, Sedlacik J, Sabin ND et al (2010) Three-dimensional susceptibility-weighted imaging and two-dimensional T2*-weighted gradient-echo imaging of intratumoral hemorrhages in pediatric diffuse intrinsic pontine glioma. Neuroradiology 52:1167&#x2013;1177. https://doi.org/10.1007/s00234-010-0771-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00234-010-0771-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E et al (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 169:13&#x2013;21. https://doi.org/10.1016/S0022-510X(99)00210-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Burgh HK, Westeneng HJ, Walhout R et al (2020) Multimodal longitudinal study of structural brain involvement in amyotrophic lateral sclerosis. Neurology 94:e2592&#x2013;e2604. https://doi.org/10.1212/WNL.0000000000009498</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009498</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Barnwell J, Al-Chalabi A, Eisen A (2012) Young-onset amyotrophic lateral sclerosis: historical and other observations. Brain 135:2883&#x2013;2891. https://doi.org/10.1093/brain/aws144</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws144</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalra S, M&#xfc;ller H-P, Ishaque A et al (2020) A prospective harmonized multicenter DTI study of cerebral white matter degeneration in ALS. Neurology 95:e943&#x2013;e952. https://doi.org/10.1212/WNL.0000000000010235</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000010235</ArticleId></ArticleIdList></Reference><Reference><Citation>Geyer S, Weiss M, Reimann K et al (2011) Microstructural parcellation of the human cerebral cortex &#x2013; from brodmann&#x2019;s post-mortem map to in vivo mapping with high-field magnetic resonance imaging. Front Hum Neurosci 5:19. https://doi.org/10.3389/fnhum.2011.00019</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnhum.2011.00019</ArticleId></ArticleIdList></Reference><Reference><Citation>Duyn JH, van Gelderen P, Li TQ et al (2007) High-field MRI of brain cortical substructure based on signal phase. Proc Natl Acad Sci U S A 104:11796&#x2013;11801. https://doi.org/10.1073/pnas.0610821104</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0610821104</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosottini M, Donatelli G, Costagli M et al (2016) High-resolution 7T MR imaging of the motor cortex in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 37:455&#x2013;461. https://doi.org/10.3174/ajnr.A4562</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A4562</ArticleId></ArticleIdList></Reference><Reference><Citation>Butman JA, Floeter MK (2007) Decreased thickness of primary motor cortex in primary lateral sclerosis. AJNR Am J Neuroradiol 28:87&#x2013;91</Citation></Reference><Reference><Citation>Costagli M, Donatelli G, Biagi L et al (2016) Magnetic susceptibility in the deep layers of the primary motor cortex in amyotrophic lateral sclerosis. Neuroimage Clin 12:965&#x2013;969. https://doi.org/10.1016/j.nicl.2016.04.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2016.04.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweitzer AD, Liu T, Gupta A et al (2015) Quantitative susceptibility mapping of the motor cortex in amyotrophic lateral sclerosis and primary lateral sclerosis. AJR Am J Roentgenol 204:1086&#x2013;1092. https://doi.org/10.2214/AJR.14.13459</Citation><ArticleIdList><ArticleId IdType="doi">10.2214/AJR.14.13459</ArticleId></ArticleIdList></Reference><Reference><Citation>Koo TK, Li MY (2016) A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 15:155&#x2013;163. https://doi.org/10.1016/j.jcm.2016.02.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcm.2016.02.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Leigh PN, Abrahams S, Al-Chalabi A et al (2003) The management of motor neurone disease. J Neurol Neurosurg Psychiatry 74(Suppl 4):iv32&#x2013;iv47. https://doi.org/10.1136/jnnp.74.suppl_4.iv32</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.74.suppl_4.iv32</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;hnlein P, Gdynia HJ, Sperfeld AD et al (2008) Diagnosis and treatment of bulbar symptoms in amyotrophic lateral sclerosis. Nat Clin Pract Neurol 4:366&#x2013;374. https://doi.org/10.1038/ncpneuro0853</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncpneuro0853</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J, Qi F, Wang N et al (2014) Increased iron level in motor cortex of amyotrophic lateral sclerosis patients: an in vivo MR study. Amyotroph Lateral Scler Frontotemporal Degener 15:357&#x2013;361. https://doi.org/10.3109/21678421.2014.906618</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.906618</ArticleId></ArticleIdList></Reference><Reference><Citation>Donatelli G, Caldarazzo Ienco E, Costagli M et al (2019) MRI cortical feature of bulbar impairment in patients with amyotrophic lateral sclerosis. Neuroimage Clin 24:101934. https://doi.org/10.1016/j.nicl.2019.101934</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2019.101934</ArticleId></ArticleIdList></Reference><Reference><Citation>Zecca L, Youdim MBH, Riederer P et al (2004) Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5:863&#x2013;873. https://doi.org/10.1038/nrn1537</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1537</ArticleId></ArticleIdList></Reference><Reference><Citation>Dean KE, Shen B, Askin G et al (2021) A specific biomarker for amyotrophic lateral sclerosis: Quantitative susceptibility mapping. Clin Imaging 75:125&#x2013;130. https://doi.org/10.1016/j.clinimag.2020.12.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinimag.2020.12.018</ArticleId></ArticleIdList></Reference><Reference><Citation>Endo H, Sekiguchi K, Shimada H et al (2018) Low signal intensity in motor cortex on susceptibility-weighted MR imaging is correlated with clinical signs of amyotrophic lateral sclerosis: a pilot study. J Neurol 265:552&#x2013;561. https://doi.org/10.1007/s00415-017-8728-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-017-8728-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Canna A, Trojsi F, Di Nardo F et al (2021) Combining structural and metabolic markers in a quantitative MRI study of motor neuron diseases. Ann Clin Transl Neurol 8:1774&#x2013;1785. https://doi.org/10.1002/acn3.51418</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51418</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G, Traynor BJ, Hardiman O et al (2008) Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry 79:6&#x2013;11. https://doi.org/10.1136/jnnp.2006.104828</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2006.104828</ArticleId></ArticleIdList></Reference><Reference><Citation>Paydarnia P, Mayeli M, Shafie M et al (2021) Alterations of the serum and CSF ferritin levels and the diagnosis and prognosis of amyotrophic lateral sclerosis. eNeurologicalSci 25:100379. https://doi.org/10.1016/j.ensci.2021.100379</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ensci.2021.100379</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu C-H, Allen K, Oei F et al (2016) Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflamm 3:e244. https://doi.org/10.1212/NXI.0000000000000244</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000244</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooney J, Burke T, Vajda A et al (2017) What does the ALSFRS-R really measure? A longitudinal and survival analysis of functional dimension subscores in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 88:381&#x2013;385. https://doi.org/10.1136/jnnp-2016-314661</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-314661</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>